Which item provides the description of the population to be studied in the context of Background Information?

Prepare for the ICH Good Clinical Practice (GCP) Exam for Certified Clinical Research Coordinator with engaging multiple-choice questions and detailed explanations. Elevate your understanding and expertise to excel in your certification exam!

Multiple Choice

Which item provides the description of the population to be studied in the context of Background Information?

Explanation:
Background Information should include a description of who will be studied, outlining the characteristics of the population, including relevant disease state and key demographics, so readers understand the study’s scope and relevance. The document that provides this exact information is the description of the population to be studied, because it explicitly states who is being studied and what defines that group, which is essential for assessing eligibility and applicability of results. The other items serve different roles: the Investigator's brochure covers the investigational product’s properties, safety, and efficacy; the audit plan describes how the study will be reviewed for compliance; and the adverse event reporting plan explains how adverse events are identified and reported. None of these describe the study population.

Background Information should include a description of who will be studied, outlining the characteristics of the population, including relevant disease state and key demographics, so readers understand the study’s scope and relevance. The document that provides this exact information is the description of the population to be studied, because it explicitly states who is being studied and what defines that group, which is essential for assessing eligibility and applicability of results.

The other items serve different roles: the Investigator's brochure covers the investigational product’s properties, safety, and efficacy; the audit plan describes how the study will be reviewed for compliance; and the adverse event reporting plan explains how adverse events are identified and reported. None of these describe the study population.

Subscribe

Get the latest from Passetra

You can unsubscribe at any time. Read our privacy policy